kte-x19 Report issue

Cell therapy Orphan Drug FDA Approved FDA Breakthrough Therapy FDA
Back

Drug Pricing Summary

VA Big4

$284904.5200

VA FSS

$373000.0000

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
brexucabtagene autoleucel 2000000 / 68 mL (68 mL SUSPENSION) $284904.5200 VA Big4
  • TECARTUS (1)
    		•  Gilead Sciences, Inc.
    brexucabtagene autoleucel 2000000 / 68 mL (68 mL SUSPENSION) $373000.0000 VA FSS
  • TECARTUS (1)
    		•  Gilead Sciences, Inc.

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue